Phoenix Neurological Associates,
Ltd.
5090 N. 40th Street
Suite 250
Phoenix, AZ 85018
Phone: (602) 258-3354
Fax: (602) 258-3368
email Phoenix Neurological Associates (If you have an urgent medical issue, do not email; please call us instead.)
January 2013: New publications by our physicians and staff. Read more
A pilot trial of memantine and riluzole in ALS: Correlation to CSF biomarkers
A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS.
Whole-genome analysis of sporadic amyotrophic lateral sclerosis.
Brachial amyotrophic diplegia: a slowly progressive motor neuron disorder.
Chronic Inflammatory Demyelinating Polyneuropathy
Clinical spectrum of chronic acquired demyelinating polyneuropathies.
Distal acquired demyelinating symmetric neuropathy.
IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab.
Treatment of IgM antibody associated polyneuropathies using rituximab.
Rituximab in the treatment of dermatomyositis: an open-label pilot study.
Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy.
Pilot trial of etanercept in the treatment of inclusion-body myositis.
Clinical and genetic aspects of distal myopathies.
Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline data.
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.
Management of myasthenia gravis.
Peripheral neuropathy in an outpatient cohort of patients with Sjögren's syndrome.
Peripheral neuropathies in Waldenström's macroglobulinaemia.
Chronic acquired demyelinating polyneuropathies.
IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab.
Treatment of IgM antibody associated polyneuropathies using rituximab.
Challenges in the identification of cobalamin-deficiency polyneuropathy.
Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics.
Inflammatory myopathy with cytochrome oxidase negative muscle fibers: methotrexate treatment.